Bailey’s CBD Launches Dog Sleep Drooling & Health Red Flags Guide For Pet Owners
Bailey’s CBD has released an educational resource created to help dog owners distinguish between normal and potentially concerning drooling during sleep. Costa Mesa, United States, October 16, 2025– …
Bailey’s CBD Releases Dog Panting While Resting Guide For Pet Health Awareness
Bailey’s CBD has published an educational guide to help dog owners differentiate between normal panting and symptoms that may indicate underlying health concerns requiring veterinary care. Costa Mesa, …
Innocan Pharma Secures Patent for LPT-CBD in Japan, Strengthening Global IP Portfolio
InnoCan Pharma ( ($TSE:INNO) ) just unveiled an announcement. Innocan Pharma announced that its patent for the Liposomal CBD Injection Technology …
Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
Detailed price information for Innocan Pharma Corp (INNO-CN) from The Globe and Mail including charting and trades.
Trump’s CBD Medicare signal sparks 36% boost in cannabis stocks — but should investors hold or brace for policy risks?
Cannabis investors recently saw a jolt of optimism after President Donald Trump signaled support for covering CBD oil under Medicare. With the news, stock prices soared. A few of the companies that …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Charlie’s Holdings (OTCQB:CHUC) to Discontinue Hemp/CBD Product Sales
Don Polly Division closure will help facilitate uplist to a national securities exchange and will remove hemp/CBD-related products trading restrictions on Charlie’s common stock. COSTA MESA, CA / …
CBD Life Sciences Inc. (CBDL) Secures Major Hemp Flower Order From Bronx Dispensary Smoking Scholars Amid Explosive Growth
Detailed price information for Cbd Life Sciences Inc (CBDL) from The Globe and Mail including charting and trades.
The Hemp War
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay …
Aurora Cannabis Lifts Outlook As CEO Hails Record Medical Marijuana Growth In Q2
Looking ahead, Aurora expects its third-quarter 2026 consolidated revenue to increase year over year, led by 8% to 12% growth in global medical cannabis sales. Management also projects continued …
Cannabis Stocks Jump on Trump’s CBD Endorsement
THE WHAT? Cannabis shares surged after Donald Trump backed cannabidiol (CBD) for senior healthcare. THE DETAILS Tilray Brands rose 42%, Aurora Cannabis 25%, Canopy Growth 18%, and Cronos Group 15.5%, …
This 1 Cannabis Dividend Stock Yields 3%
Cannabis stocks are having an interesting week, thanks to President Donald Trump’s renewed interest in making cannabidiol (CBD) available to seniors via Medicare. The president posted a video Sunday on his Truth Social feed that promoted the health benefits of...
Canopy Growth (CGC) Stock Is Falling Wednesday: What’s Going On?
Shares of Canopy Growth Corp (NASDAQ: CGC) are trading lower Wednesday, pulling back from a sharp rally on Monday. The stock is seeing a downturn as initial excitement wanes following a social media …
Tilray and BeautyHealth Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after signs of weakening consumer health and a cautious outlook for the upcoming holiday season emerged.
These Are the 3 Top-Rated Cannabis Stocks to Buy as Trump Backs CBD
Cannabis stocks soared after President Donald Trump shared a video that promoted the health benefits of CBD (cannabidiol) for seniors. The video suggested Medicare coverage for the substance and said …



Recent Comments